RU2109510C1 - Способ ингибирования, таблетка и капсула - Google Patents
Способ ингибирования, таблетка и капсула Download PDFInfo
- Publication number
- RU2109510C1 RU2109510C1 RU96108120A RU96108120A RU2109510C1 RU 2109510 C1 RU2109510 C1 RU 2109510C1 RU 96108120 A RU96108120 A RU 96108120A RU 96108120 A RU96108120 A RU 96108120A RU 2109510 C1 RU2109510 C1 RU 2109510C1
- Authority
- RU
- Russia
- Prior art keywords
- dye
- red
- yellow
- thienyl
- pigment
- Prior art date
Links
- 0 CC(C1C)C(C=O)C2=C1C=C(*)C(*)C2 Chemical compound CC(C1C)C(C=O)C2=C1C=C(*)C(*)C2 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1995/000287 WO1996033701A1 (fr) | 1995-04-24 | 1995-04-24 | Inhibition de la photodecomposition des 2-oxindoles-3-substitues |
| IBPCT/IB95/00287 | 1995-04-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2109510C1 true RU2109510C1 (ru) | 1998-04-27 |
| RU96108120A RU96108120A (ru) | 1998-07-10 |
Family
ID=36997502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU96108120A RU2109510C1 (ru) | 1995-04-24 | 1995-04-24 | Способ ингибирования, таблетка и капсула |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0827399A1 (fr) |
| JP (1) | JPH10506635A (fr) |
| KR (1) | KR100189585B1 (fr) |
| CN (1) | CN1053667C (fr) |
| AP (1) | AP607A (fr) |
| AR (1) | AR002728A1 (fr) |
| AU (1) | AU692378B2 (fr) |
| BG (1) | BG100531A (fr) |
| BR (1) | BR9602024A (fr) |
| CO (1) | CO4700418A1 (fr) |
| FI (1) | FI973988A0 (fr) |
| HR (1) | HRP960194A2 (fr) |
| HU (1) | HU216544B (fr) |
| IL (1) | IL117969A0 (fr) |
| IS (1) | IS4339A (fr) |
| MA (1) | MA23848A1 (fr) |
| NO (1) | NO961622L (fr) |
| NZ (1) | NZ286432A (fr) |
| OA (1) | OA10286A (fr) |
| PE (1) | PE34397A1 (fr) |
| RO (1) | RO113305B1 (fr) |
| RU (1) | RU2109510C1 (fr) |
| SG (1) | SG64924A1 (fr) |
| SI (1) | SI9600133A (fr) |
| SK (1) | SK51296A3 (fr) |
| TR (1) | TR199600300A2 (fr) |
| UA (1) | UA42739C2 (fr) |
| WO (1) | WO1996033701A1 (fr) |
| YU (1) | YU25096A (fr) |
| ZA (1) | ZA963210B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021510067A (ja) | 2017-12-29 | 2021-04-15 | クラフト・フーズ・グループ・ブランズ・エルエルシー | 天然安定剤を使用した水中油型エマルションの酸化安定性の向上 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
| TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 JP JP8532298A patent/JPH10506635A/ja active Pending
- 1995-04-24 RU RU96108120A patent/RU2109510C1/ru active
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/fr not_active Application Discontinuation
- 1995-04-24 SK SK512-96A patent/SK51296A3/sk unknown
- 1995-04-24 UA UA96041574A patent/UA42739C2/uk unknown
- 1995-04-24 EP EP95914494A patent/EP0827399A1/fr not_active Ceased
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/es unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/xx unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/xx unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-19 IS IS4339A patent/IS4339A/is unknown
- 1996-04-22 PE PE1996000275A patent/PE34397A1/es not_active Application Discontinuation
- 1996-04-22 CN CN96105084A patent/CN1053667C/zh not_active Expired - Fee Related
- 1996-04-22 CO CO96019210A patent/CO4700418A1/es unknown
- 1996-04-22 RO RO96-00843A patent/RO113305B1/ro unknown
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/hr not_active Application Discontinuation
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/xx unknown
- 1996-04-23 HU HU9601057A patent/HU216544B/hu not_active IP Right Cessation
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/ko not_active IP Right Cessation
- 1996-04-23 BG BG100531A patent/BG100531A/xx unknown
- 1996-04-23 YU YU25096A patent/YU25096A/sh unknown
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 MA MA24209A patent/MA23848A1/fr unknown
- 1996-04-23 NO NO961622A patent/NO961622L/no unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-24 BR BR9602024A patent/BR9602024A/pt active Search and Examination
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
- 1996-04-24 SI SI9600133A patent/SI9600133A/sl not_active IP Right Cessation
-
1997
- 1997-10-17 FI FI973988A patent/FI973988A0/fi unknown
Non-Patent Citations (1)
| Title |
|---|
| 1. RU 2017729 С (Пфайзер Инк.), 15.08.94, A 61 K 31/40. 2. DE 3526546 А1 (R.P.Scherer GmbH), 29.01.87, A 61 K 9/48. 3. US 3784684 А (Friedrich Bossert и др.), 08.01.74, колонка 3, A 61 J 3/07. 4. JP 60-105611 А (Nippon Chemipher K.K.), 11.06.85, A 61 K 9/48. 5. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3254219B2 (ja) | 安定な経口用のｃｉ−９８１製剤およびその製法 | |
| RU2426530C2 (ru) | Твердый препарат | |
| FI92904C (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| FR2684876A1 (fr) | Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation. | |
| CA2501587C (fr) | Preparation solide ayant une phase contenant un melange homogene d'un sensibilisateur a l'insuline et d'un autre ingredient actif | |
| JPWO2005099760A1 (ja) | 固形製剤 | |
| NL193440C (nl) | Farmaceutisch preparaat met analgetische werking. | |
| BG63329B1 (bg) | Лекарствени форми, съдържащи ибупрофен и кодеин | |
| KR20060061383A (ko) | 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제 | |
| MXPA04011801A (es) | Composicion farmaceutica que contiene oxcarbazepina con liberacion controlada de la substancia activa. | |
| FR2931677A1 (fr) | Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs | |
| RU2109510C1 (ru) | Способ ингибирования, таблетка и капсула | |
| CA2003478A1 (fr) | Combinaison d'un inhibiteur de hmg coa reductase et d'un autre type d'agent reducteur du cholesterol serique et methode de reduction du cholesterol serique par l'emploi de ladite combinaison | |
| RU2292891C2 (ru) | Фармацевтическая композиция с антигиперлипидемической активностью | |
| US5789407A (en) | Method of treating depression with certain triazine derivatives | |
| AU780341B2 (en) | Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone | |
| CA2216931A1 (fr) | Inhibition de la photodecomposition des 2-oxindoles-3-substitues | |
| AU620658B2 (en) | Memory-enhancing compositions containing dioxopiperidine derivatives | |
| EP1946778A1 (fr) | Combinaison de substance active pour le traitement des diabètes | |
| US4333945A (en) | Thiazoline and imidazoline derivatives useful as minor tranquilizers | |
| GB2206491A (en) | Anti-anxiogenic compositions containing dioxopiperidine derivatives | |
| US5177086A (en) | Memory-enhancing compositions containing dioxopiperidine derivatives | |
| RU96108120A (ru) | Способ ингибирования, таблетка и капсула | |
| TH11684B (th) | สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับยั้ง HMG-CoA รีดักเตส |